Sign In to View Organizational & Contract Pricing.
About This Item
Linear Formula:
7Li2SO4
CAS Number:
Molecular Weight:
110.09
PubChem Substance ID:
UNSPSC Code:
12352302
Product Name
Lithium-7Li2 sulfate, 99 atom % 7Li
InChI
1S/2Li.H2O4S/c;;1-5(2,3)4/h;;(H2,1,2,3,4)/q2*+1;/p-2/i2*1+0;
InChI key
INHCSSUBVCNVSK-ONPSQTMSSA-L
SMILES string
[7Li+].[7Li+].[O-]S([O-])(=O)=O
isotopic purity
99 atom % 7Li
form
solid
mass shift
depleted
Related Categories
Application
- Chemical synthesis of labeled compounds
- Advanced materials research and development
- Quality control reference standards
- Analytical method development
- Advanced materials research and development
- Quality control reference standards
- Analytical method development
Features and Benefits
Features
Benefits
- Cost-effective solution for Lithium-7Li2 sulfate 99 atom % 7Li applications.
- Exceptional stability and compatibility with various ingredients.
- High purity of Lithium-7Li2 sulfate 99 atom % 7Li ensures optimal performance.
- Versatile use in different formulations involving Lithium-7Li2 sulfate 99 atom % 7Li.
Benefits
- Increases market competitiveness of products containing Lithium-7Li2 sulfate 99 atom % 7Li.
- Improves overall product quality and consumer satisfaction.
- Enhances product efficacy and reliability in formulations.
- Reduces time to market for products utilizing Lithium-7Li2 sulfate 99 atom % 7Li.
General description
Lithium-7Li2 sulfate 99 atom % 7Li is a high-purity isotope product with a unique chemical profile that belongs to the class of isotopes. Produced by Sigma-Aldrich, we are committed to providing quality isotope products and a reliable supply chain. Available in industrial and pre-pack quantities.
Packaging
This product may be available from bulk stock and can be packaged on demand. For information on pricing, availability and packaging, please contact Stable Isotopes Customer Service.
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Eye Irrit. 2
Storage Class
13 - Non Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Mareike Hütten et al.
PloS one, 9(8), e104564-e104564 (2014-08-12)
Fibrous tissue growth and loss of residual hearing after cochlear implantation can be reduced by application of the glucocorticoid dexamethasone-21-phosphate-disodium-salt (DEX). To date, sustained delivery of this agent to the cochlea using a number of pharmaceutical technologies has not been
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service